Dr. ASHAR IQBAL LODI
Sri Aurobindo Institute of Medical Sciences, Chirayu Medical College & Hospital, Kasturba Medical College, Mangalore
About
More than 10 years of experience in the field of oncology. Currently, working as Associate Professor & Consultant, Radiation Oncology at Sri Aurobindo Medical College & PG Institute, Indore. Has completed MD Radiation Oncology from Madhya Pradesh Medical Science University. MBBS graduate from Kasturba Medical College, Mangalore affiliated to the prestigious Manipal Academy of Higher Education.
Interested in the clinical aspects of diagnosis, treatment of various cancers and cancer awareness & prevention. Has been trained in high precision Radiation therapy treatment including SBRT, VMAT, IGRT, IMRT, HDR Brachytherapy of various sites. Special interest in Breast, Cervix, Lung, Genitourinary, Gynecological, CNS, Head & Neck malignancies. Has performed more than 600 successful ICRT procedures.
Research interests : Precision Radiotherapy, Brachytherapy, Chemotherapy, Preventive Oncology
Employment
-
Sri Aurobindo Institute of Medical Sciences Associate Professor2026 - Present
-
Sri Aurobindo Institute of Medical Sciences Assistant Professor2020 - 2026
-
Chirayu Medical College & Hospital Senior Resident2019 - 2020
Education
-
Sri Aurobindo Institute of Medical Sciences MD2016 - 2019
-
Kasturba Medical College, Mangalore MBBS2008 - 2014
Projects & Funding
Projects & funding information is unavailable.
Publications (6)
- Assessment of progression-free survival and overall survival in patients of glioblastoma post-radiation therapy Save
- Survival and analysis of patients with various central nervous tumors who received post-operative radiation therapy: A retrospective study Save
- Pituitary Carcinoma in Paediatric Age Group: A Rare Case Report Save
- Carcinoma cervix with scalp metastasis: An unusual case report Save
- Ovarian cancer with osteoblastic bone metastasis – A rare case report Save
- To evaluate volume changes on computerized tomography scan and magnetic resonance imaging-based delineation during radiotherapy treatment planning in prostate cancer Save